Skip to main content

Table 4 Comparison of Length of Stay and Number of Hospitalizations After Conversion to PP1M

From: A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China

 

Number of hospitalizations

Inpatient stays (days)

pre-PP1M

0.67 ± 0.96

52.80 ± 60.54

Post-PP1M

0.22 ± 0.42

16.33 ± 29.48

T

2.56

1.73

P

≤ 0.01

<0.05